Cargando…

Rosuvastatin Potentiates Gonadotropin-Lowering Effects of Metformin in Postmenopausal Women: A Pilot Study

INTRODUCTION: Metformin reduces elevated levels of FSH and LH. In some studies, gonadotroph secretory function was inhibited by statins. The aim of the present study was to investigate whether statin therapy modulates the impact of metformin on hypothalamic-pituitary-gonadal axis activity in postmen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krysiak, Robert, Kowalcze, Karolina, Okopień, Bogusław
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10233706/ https://www.ncbi.nlm.nih.gov/pubmed/36791677 http://dx.doi.org/10.1159/000528939

Ejemplares similares

Vitamin D Status Determines the Impact of Metformin on Gonadotropin Levels in Postmenopausal Women
por: Krysiak, Robert, et al.
Publicado: (2023)

Impaired Gonadotropin-Lowering Effects of Metformin in Postmenopausal Women with Autoimmune Thyroiditis: A Pilot Study
por: Krysiak, Robert, et al.
Publicado: (2023)

Impaired Prolactin-Lowering Effects of Metformin in Women with Polycystic Ovary Syndrome
por: Krysiak, Robert, et al.
Publicado: (2023)

The Effect of Metformin on Plasma Prolactin Levels in Young Women with Autoimmune Thyroiditis
por: Krysiak, Robert, et al.
Publicado: (2023)

Impaired metabolic effects of metformin in men with early-onset androgenic alopecia
por: Krysiak, Robert, et al.
Publicado: (2021)

Cardiometabolic Effects of Cabergoline and Combined Oral Contraceptive Pills in Young Women with Hyperprolactinemia: A Pilot Study
por: Krysiak, Robert, et al.
Publicado: (2023)

The impact of hypotestosteronemia on cardiometabolic effects of atorvastatin in men with hypercholesterolemia: a pilot study
por: Krysiak, Robert, et al.
Publicado: (2021)

Cabergoline-Induced Hypoprolactinemia May Attenuate Cardiometabolic Effects of Atorvastatin: A Pilot Study
por: Krysiak, Robert, et al.
Publicado: (2022)

The impact of rosuvastatin on hypothalamic–pituitary–testicular axis activity in metformin-treated and metformin-naïve men with low testosterone levels: a pilot study
por: Krysiak, Robert, et al.
Publicado: (2021)

Cardiometabolic profile of young women with hypoprolactinemia
por: Krysiak, Robert, et al.
Publicado: (2022)

Sexual Function and Depressive Symptoms in Young Women with Euthyroid Hashimoto’s Thyroiditis Receiving Vitamin D, Selenomethionine and Myo-Inositol: A Pilot Study
por: Krysiak, Robert, et al.
Publicado: (2023)

The impact of exogenous vitamin D on thyroid autoimmunity in euthyroid men with autoimmune thyroiditis and early-onset androgenic alopecia
por: Krysiak, Robert, et al.
Publicado: (2021)

Cardiometabolic Risk Factors in Rosuvastatin-Treated Men with Mixed Dyslipidemia and Early-Onset Androgenic Alopecia
por: Krysiak, Robert, et al.
Publicado: (2021)

Myo-Inositol Potentiates the Inhibitory Effect of Metformin on Prolactin Levels
por: Krysiak, Robert, et al.
Publicado: (2023)

The effect of short-term metformin treatment on plasma prolactin levels in bromocriptine-treated patients with hyperprolactinaemia and impaired glucose tolerance: a pilot study
por: Krysiak, Robert, et al.
Publicado: (2014)

Pleiotropic Action of Short-Term Metformin and Fenofibrate Treatment, Combined With Lifestyle Intervention, in Type 2 Diabetic Patients With Mixed Dyslipidemia
por: Pruski, Maciej, et al.
Publicado: (2009)

Vitamin D Status Determines Cardiometabolic Effects of Cabergoline in Women with Elevated Prolactin Levels: A Pilot Study
por: Krysiak, Robert, et al.
Publicado: (2023)

Sexual function and depressive symptoms in young women with elevated macroprolactin content: a pilot study
por: Krysiak, Robert, et al.
Publicado: (2016)

The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome
por: Krysiak, Robert, et al.
Publicado: (2020)

Correction to: The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome
por: Krysiak, Robert, et al.
Publicado: (2021)

Minipuberty in Sons of Women with Low Vitamin D Status during Pregnancy
por: Kowalcze, Karolina, et al.
Publicado: (2023)

Coexistence of primary aldosteronism and Hashimoto’s thyroiditis
por: Krysiak, Robert, et al.
Publicado: (2011)

The effect of bezafibrate and omega-3 fatty acids on lymphocyte cytokine release and systemic inflammation in patients with isolated hypertriglyceridemia
por: Krysiak, Robert, et al.
Publicado: (2011)

Recurrent pancreatitis induced by hyperparathyroidism in pregnancy
por: Krysiak, Robert, et al.
Publicado: (2010)

Endocrine Symptoms as the Initial Manifestation of Wilson’s Disease
por: Krysiak, Robert, et al.
Publicado: (2012)

The role of adipokines in connective tissue diseases
por: Krysiak, Robert, et al.
Publicado: (2012)

Pleiotropic Effects of Atorvastatin and Fenofibrate in Metabolic Syndrome and Different Types of Pre-Diabetes
por: Krysiak, Robert, et al.
Publicado: (2010)

Effect of insulin resistance on gonadotropin and bone mineral density in nondiabetic postmenopausal women
por: Ye, Shujin, et al.
Publicado: (2023)

Effect of Oral Semaglutide on the Pharmacokinetics of Levonorgestrel and Ethinylestradiol in Healthy Postmenopausal Women and Furosemide and Rosuvastatin in Healthy Subjects
por: Jordy, Andreas B., et al.
Publicado: (2021)

Bone phenotypes in response to gonadotropin misexpression: the role for gonadotropins in postmenopausal osteoporosis
por: Mansell, Jason P
Publicado: (2009)

The Effect of PCSK9 Inhibition on the Stabilization of Atherosclerotic Plaque Determined by Biochemical and Diagnostic Imaging Methods
por: Basiak, Marcin, et al.
Publicado: (2023)

Gut Microbiome Associates With Lipid-Lowering Effect of Rosuvastatin in Vivo
por: Liu, Yinhui, et al.
Publicado: (2018)

The APOB gene polymorphism in the pathogenesis of gallstone disease in pre- and postmenopausal women
por: Rudzińska, Karolina, et al.
Publicado: (2015)

Gonadotropins and Their Association with the Risk of Prediabetes and Type 2 Diabetes in Middle-Aged Postmenopausal Women
por: Stefanska, Anna, et al.
Publicado: (2019)

Plasma Concentrations of New Biochemical Markers of Atherosclerosis in Patients with Dyslipidemia—A Pilot Study
por: Kosowski, Michał, et al.
Publicado: (2022)

Lipid lowering efficacy and safety of Ezetimibe combined with rosuvastatin compared with titrating rosuvastatin monotherapy in HIV-positive patients
por: Saeedi, Ramesh, et al.
Publicado: (2015)

Plasma Concentrations of Cytokines in Patients with Combined Hyperlipidemia and Atherosclerotic Plaque before Treatment Initiation—A Pilot Study
por: Basiak, Marcin, et al.
Publicado: (2022)

Pharmacokinetic Evaluation of a Drug Transporter Cocktail Consisting of Digoxin, Furosemide, Metformin, and Rosuvastatin
por: Stopfer, P, et al.
Publicado: (2016)

Metformin reduces the expression of NADPH oxidase and increases the expression of antioxidative enzymes in human monocytes/macrophages cultured in vitro
por: Bułdak, Łukasz, et al.
Publicado: (2017)

Effect of massage in postmenopausal women with insomnia – A pilot study
por: Oliveira, Denise, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_mhkbc17rbck310pj2raue8abas